Faeth Therapeutics (FTH)

• Market cap: $702M
• 1 day: -5.48%
• 5 days: -4.25%
• 1 month: 8.96%
• 3 months: 2.33%
• 6 months: 197.38%
• Year to date: 182.28%
• 1 year: 264.17%
• 5 years: -81.84%
• 10 years: -92.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Employees: 29